The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS: Savannah Resources Jumps On Deal With Rio Tinto

Mon, 22nd Jun 2015 10:20

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Monday.
-------
FTSE 100 WINNERS
-------
Carnival, up 4.1% at 3,308 pence. Deutsche Bank upgrades Carnival to Buy from Hold, lifting its price target to 3,525p from 3,400p, with the bank saying it expects the second-quarter results from the cruiser operator to be above the upper end of the company's guidance. Analyst Richard Carter says he expects Carnival to demonstrate further booking and pricing recovery coupled with more operational momentum in its Carnival brand.

Sky, up 3.2%. Shares in the broadcaster are higher after the Murdoch family is reported to have rejected bids for its stake in Sky, stoking speculation that they intend to make a new attempt to take full control of the company, the Daily Telegraph reported on Saturday. The most recent bid is understood to have come from Vivendi, the French media conglomerate, while Vodafone Group also made an informal approach for the Murdoch's stake in Sky last year, the newspaper said.

Severn Trent, up 2.9% Canadian investment giant Borealis Infrastructure is considering a GBP5 billion approach for Severn Trent, two years after the FTSE 100 water company rejected an earlier takeover attempt, The Sunday Times reported. The newspaper, citing "sources close to the situation", said it is understood that the two sides opened talks last month, and discussions are at an early stage with no certainty a deal.

Capita, up 2.2%. The outsourcing company said that NHS England has named it as the preferred bidder to establish a single provider framework for administrative support functions for primary care across the UK. Capita said its selection includes an initial contract to manage and deliver services in England. The four-year sole provider framework has a maximum total value of GBP1 billion. Under the framework, the initial contract, which runs for seven to 10 years, for Capita to provide administrative support services for primary care in England is expected to be valued at up to about GBP400 million.
-------
FTSE 100 LOSERS
-------
Randgold Resources, down 1.8%, Fresnillo, down 0.7%. Precious metals miners are amongst the handful of FTSE 100 stocks which are trading lower Monday after the price of gold sunk below USD1,200 an ounce. Gold currently trades at USD1,195.35.
-------
FTSE 250 WINNERS
-------
Spire Healthcare Group, up 9.3%. The private healthcare provider said the major shareholder in South Africa-based private hospital group Mediclinic has acquired a 29.9% stake in the company for GBP432 million. The shareholder, Remgro, has acquired the stake in Spire at 360 pence per share. Spire shares closed at 320 pence on Friday. Spire said the intention is for Mediclinic to acquire the stake in Spire from Remgro in the "near future". Mediclinic and Remgro have confirmed they have no intention to acquiring the rest of Spire.

Bwin.Party Digital Entertainment, up 2.1%. The online gaming operator shares are higher after it said it has agreed to sell its entire interest in World Poker Tour to Ourgame International Holdings for USD35 million in cash. Bwin.party Digital Entertainment said it will continue to sponsor a number of World Poker Tour events and television shows in the US and Europe until the end of December 2016, and will have first refusal on any sponsorship opportunities that could become available until the end of December 2016.
-------
FTSE 250 LOSERS
-------
WS Atkins, down 1.4%. Panmure Gordon downgraded the project designer, engineer and management consultancy to Hold from Buy, saying the current share price does not reflect the near-term risks in its rail business.
-------
AIM ALL-SHARE WINNERS
-------
Savannah Resources, up 85%. The company said it has established a joint venture with mining giant Rio Tinto, which will result in both companies combining their heavy mineral sands projects in Mozambique. Under the deal, Savannah's Mutamba, Dongane and Jangamo prospects, together called the Jangamo project, will be combined with Rio Tinto's Chilubane project. Those prospects border one another and Savannah will operate the joint venture and have the ability to earn up to a 51% stake in the newly combined project by conducting the scoping, pre-feasibility and feasibility studies. Rio Tinto shares are up 0.3%.

Imaginatik, up 38%. The Consultancy and technology products company on Friday said it knows of no reason for the rise in its share price last week. However, it said it is aware that Quob Park Estates has been acquiring shares in the company. It added it has not received a notification of Quob's interest in its shares and has had no contact with the investment vehicle.

Lansdowne Oil & Gas, up 18%. The company said PSE Seven Heads and a subsidiary of PSE Kindsale Energy has entered into a contract with Diamond Offshore Drilling UK for the Ocean Guardian drilling rig to be used to drill a well at the Midleton Prospect in the North Celtic Sea. Kinsale Energy holds an 80% interest in the SEL 4/07 licence, with Lansdowne owning the remaining 20%. PSE Seven Heads is the operator of the licence.

ReNeuron Group, up 12%. The stem cell therapy company said it has extended its existing research collaboration with Australia-based Benitec Biopharma following positive results from early studies conducted by the pair.
-------
AIM ALL-SHARE LOSERS
-------
Armstrong Ventures, off 20%. The investment company said it is "hopeful" about the future, as it said it is operating against tough conditions, which it doesn't see improving in the near term. Chariman Haresh Kanabar said the general market conditions have been difficult for small AIM-listed companies focused on the resources and energy sectors.

Richland Resources, down 13%. The company said it will delay its first sapphire sale to the third quarter of 2015, news which follows a consultation with sightholders. Richland Resources, which is developing the Capricorn Sapphire project, said it will hold a product display and education session on its first recovered sapphires at the time of the Hong Kong Jewellery show from this coming Thursday to Sunday.

By Daniel Ruiz; danielruiz@alliancenews.com; and Neil Thakrar; neilthakrar@alliancenews.com; @NeilThakrar1

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
2 Dec 2022 10:40

AIM WINNERS & LOSERS: Orosur Mining drops on disappointing assays

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
2 Dec 2022 09:31

ReNeuron loss narrows amid lower costs and surging revenue

(Alliance News) - ReNeuron Group PLC on Friday said its loss narrowed in the first half of its financial year, following lower costs, increased revenue and foreign exchange gains.

Read more
7 Oct 2022 10:32

ReNeuron says exosomes outperform alternatives at Boston summit

(Alliance News) - ReNeuron Group PLC on Friday said it presented positive new data at a leading summit of targeted therapies.

Read more
14 Sep 2022 13:19

IN BRIEF: ReNeuron promotes Financial Controller Hawkins to CFO

ReNeuron Group PLC - Bridgend, Wales-based stem cell and exosomes technology company - Promotes Financial Controller John Hawkins to chief financial officer with immediate effect. Hawkins joined the company in 2014 as financial controller and was also named as the company secretary last year. Says Hawkins is an experienced finance professional with a breadth of experience gained within "a variety of businesses, from large PLCs to family-owned SMEs".

Read more
2 Sep 2022 15:57

UK shareholder meetings calendar - next 7 days

Monday 5 September 
Highway Capital PLCAGM
Hill & Smith Holdings PLCAGM
Hydrogen Utopia International PLCAGM
LXi REIT PLCAGM
Monks Investment Trust PLCAGM
Totally PLCAGM
Tuesday 6 September 
Ashtead Group PLCAGM
Berkeley Group Holdings PLCAGM
Brickability Group PLCAGM
Castelnau Group LtdAGM
DS Smith PLCAGM
Lamprell PLCAGM
Renold PLCAGM
Wednesday 7 September 
BlueRock Diamonds PLCAGM
CVC Income & Growth LtdEGM
Halfords Group PLCAGM
Jupiter Green Investment Trust PLCAGM
Mulberry Group PLCAGM
Okyo Pharma LtdAGM
Polar Capital Holdings PLCAGM
Redcentric PLCAGM
Seed Innovations LtdAGM
Trifast PLCAGM
Yellow Cake PLCAGM
Thursday 8 September 
Atlantis Japan Growth Fund LtdAGM
Aston Martin Lagonda Global Holdings PLCGM proposed equity capital raise
Caretech Holdings PLCGM takeover by Sheikh Holdings Group
Chariot LtdAGM
Chelverton UK Dividend Trust PLCAGM
Currys PLCAGM
Euromoney Institutional Investor PLCGM re takeover offer by Astorg and Epiris
Gabelli Merger Plus+ Trust PLCGM tender offers
Invesco Asia Trust PLCAGM
LendInvest PLCAGM
Lindsell Train Investment Trust PLCAGM
Montanaro European Smaller Cos Trust PLCAGM
ScotGems PLCGM re voluntary liquidation
Semper Fortis Esports PLCAGM
Severfield PLCAGM
Speedy Hire PLCAGM
SysGroup PLCAGM
WH Ireland Group PLCAGM
XPS Pensions Group PLCAGM
Friday 9 September 
Baillie Gifford UK Growth Trust PLC
AGM
CLS Holdings PLCGM re tender offer
Gear4Music Holdings PLCAGM
Newcrest Mining LtdAGM
Pensana PLCAGM
ReNeuron Group PLCAGM
SVM UK Emerging Fund PLCAGM
Victoria Oil & Gas PLCAGM
Voyager Life PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
1 Aug 2022 14:30

EXECUTIVE CHANGES: ReNeuron promotes CFO Catherine Isted to CEO role

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

Read more
4 Jul 2022 10:22

IN BRIEF: ReNeuron annual loss narrows amid shift in strategy

ReNeuron Group PLC - Bridgend, Wales-based stem cell and exosomes technology company - Pretax loss in year to March 31 narrows to GBP11.1 million from GBP13.4 million loss a year prior. Research & development costs fall to GBP8.1 million from GBP9.5 million, with general & administrative costs at GBP3.6 million versus GBP3.7 million. Revenue drops to GBP403,000 from GBP257,000.

Read more
1 Jul 2022 13:40

IN BRIEF: ReNeuron inks deal worth up to GBP6 million in revenue

ReNeuron Group PLC - Bridgend, Wales-based stem cell and exosomes technology company - Negotiates a supplemental terms agreement with Shanghai Fosun Pharmaceutical Group Co Ltd. Company says the agreement has the potential to generate revenue of up to GBP6 million.

Read more
27 Jun 2022 15:53

UK earnings, trading statements calendar - next 7 days

Tuesday 28 June 
Appreciate Group PLCFull Year Results
ICG Enterprise Trust PLCQ1 Results
IG Design Group PLCFull Year Results
Marlowe PLCFull Year Results
Oxford BioDynamics PLCHalf Year Results
Petrofac LtdTrading Statement
Wise PLCFull Year Results
Wednesday 29 June 
B&M European Value Retail SAQ1 Results
LendInvest PLCFull Year Results
Moonpig Group PLCFull Year Results
Inspecs Group PLCFull Year Results
Mulberry Group PLCFull Year Results
ProCook Group PLCFull Year Results
Thursday 30 June 
Accsys Technologies PLCFull Year Results
Breedon Group PLCHalf Year Results
Bunzl PLCTrading Statement
Civitas Social Housing PLCFull Year Results
HgCapital Trust PLCHalf Year Results
Hunting PLCTrading Statement
Polar Capital Holdings PLCFull Year Results
PCF Group PLCFull Year Results
Renalytix PLCQ3 Results
SDCL Energy Efficiency Income Trust PLCFull Year Results
SEEEN PLCFull Year Results
Friday 1 July 
no events scheduled 
Monday 4 July 
Augmentum Fintech PLCFull Year Results
Porvair PLCHalf Year Results
ReNeuron Group PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
11 Feb 2022 13:50

IN BRIEF: ReNeuron chair steps in to run business as CEO resigns

ReNeuron Group PLC - Bridgend, Wales-based stem cell and exosomes technology - Olav Hellobo resigns as chief executive officer after seven years and will leave at the end of February. Hellobo says he decided it was time to leave following ReNeuron's recent change in strategy. The company has shifted its focus to the development of its exosomes technology platform. The platform uses stem cell technologies to develop "off the shelf" treatments for diseases. Chair Iain Ross, supported by Chief Financial Officer Catherine Isted, will run the business, ReNeuron says.

Read more
18 Jan 2022 10:58

AIM WINNERS & LOSERS: Sanderson Design lifts outlook, Gattaca lowers

AIM WINNERS & LOSERS: Sanderson Design lifts outlook, Gattaca lowers

Read more
18 Jan 2022 10:26

ReNeuron shares dive as it drops retinitis pigmentosa trials

ReNeuron shares dive as it drops retinitis pigmentosa trials

Read more
13 Jan 2022 21:12

TRADING UPDATES: Power Metal renewal; Yamana production hits target

TRADING UPDATES: Power Metal renewal; Yamana production hits target

Read more
11 Jan 2022 16:00

ReNeuron re-appoints Randolph Corteling in senior research role

ReNeuron re-appoints Randolph Corteling in senior research role

Read more
30 Nov 2021 19:13

TRADING UPDATES: Zambeef sales continue climb; Watchstone files claim

TRADING UPDATES: Zambeef sales continue climb; Watchstone files claim

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.